Nov 07, 2014 8:00 am EST Capricor Therapeutics to Hold Duchenne Muscular Dystrophy Data Presentation Call on November 18, 2014 at 9:30 a.m. ET
Oct 31, 2014 8:00 am EDT Capricor Therapeutics to Hold Third Quarter 2014 Business Update Conference Call on November 12, 2014 at 4:30 p.m. ET
Oct 14, 2014 8:00 am EDT Capricor Therapeutics Announces Acquisition of Intellectual Property Rights to Family of Natriuretic Peptides From Medtronic, Inc.
Oct 09, 2014 8:22 am EDT Capricor Therapeutics Announces Plans to Pursue a Cenderitide Clinical Program and Enters Into Research Support Agreement With Insulet Corporation
Oct 06, 2014 7:00 am EDT Capricor Announces Plans to Pursue Clinical Program for the Treatment of Duchenne Muscular Dystrophy With Cardiosphere-Derived Cells (CDCs)
Sep 18, 2014 8:26 am EDT Capricor Presents Safety and Preliminary Efficacy Results From ALLSTAR Phase I Clinical Trial at TCT 2014
Aug 13, 2014 10:18 am EDT Capricor Therapeutics Reports Second Quarter 2014 Financial & Business Highlights
Aug 04, 2014 8:27 am EDT Capricor Therapeutics to Hold Second Quarter 2014 Business Update Conference Call on August 13, 2014 at 4:30 p.m. Eastern Time
Jul 16, 2014 7:59 am EDT Capricor Announces Encouraging Results From Phase I ALLSTAR Trial; Phase II Trial Underway
Jun 23, 2014 9:02 am EDT Capricor Therapeutics to Present at the First Regenerative Medicine Forum at BIO International Convention